Company Snapshot: Nemaura Medical Inc.

NMRD
Last	Change	Volume	High	Low

Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.

Client News

1. Jul 18 2019 Nemaura Medical Inc. Appoints Chris Avery as Vice President of Global Business Operations to Support Global Commercial Launch of SugarBEAT®
2. Jul 10 2019 Nemaura Medical Inc. Submits De Novo 510(k) Application for SugarBEAT® to the U.S. Food and Drug Administration
3. Jun 17 2019 Nemaura Provides Fiscal 2019 Year-End Business Update
4. Jun 14 2019 Nemaura Medical Interview to Air on Bloomberg International on the RedChip Money Report